Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Avastin
Company Monitoring Page for Avastin
latest headlines for company on cafepharma
EU OKs Roche's Avastin for ovarian cancer
Reuters
Fri, 12/23/11 - 08:50 am
Tags:
Europe
,
Avastin
,
ovarian cancer
,
Roche
New Setback for Avastin as Breast Cancer Treatment
NY Times, NY
Thu, 12/8/11 - 11:39 am
Tags:
breast cancer
,
Avastin
,
Roche
,
Genentech
CEO: Roche would consider more money-back deals
Fierce Pharma
Thu, 12/1/11 - 12:16 pm
Tags:
Avastin
,
Roche
,
Severin Schwan
Winners and Losers of Roche's Avastin Woes
Motley Fool
Tue, 11/29/11 - 06:48 pm
Tags:
Roche
,
Avastin
,
breast cancer
,
Merck
,
GSK
,
Bristol-Myers Squibb
,
Eli Lilly
,
Teva Pharmaceuticals
,
Dr Reddy's
,
Watson
,
Seattle Genetics
Joining FDA, Canada pulls Avastin's breast cancer indication
Fierce Pharma
Tue, 11/29/11 - 01:40 pm
Tags:
Canada
,
Avastin
,
breast cancer
,
Roche
F.D.A. Revokes Approval of Avastin as Breast Cancer Drug
NY Times, NY
Fri, 11/18/11 - 11:51 am
Tags:
FDA
,
Avastin
,
breast cancer
,
Roche
,
Genentech
VA Reinstates Avastin Usage For Eye Disease
Pharmalot
Thu, 11/10/11 - 01:13 pm
Tags:
Veterans Administration
,
Avastin
,
Lucentis
,
age-related macular degeneration
,
Genentech
Roche Unit Didn't Follow Procedures To Prevent Drug Contamination; Galena Presents Positive NeuVax Clinical Results
Biomed Reports
Sun, 11/6/11 - 12:25 pm
Tags:
Roche
,
Avastin
,
Galena Biopharma
,
NeuVax
,
breast cancer
Doctors Are Split On Avastin For Breast Cancer
Pharmalot
Thu, 10/27/11 - 11:12 am
Tags:
breast cancer
,
physicians
,
Avastin
,
Roche
,
Taxol
Doctors Grow Wary of Avastin for Eye Treatment
NY Times, NY
Wed, 10/5/11 - 10:55 am
Tags:
Genentech
,
Avastin
,
Lucentis
New label on Genentech's Avastin warns of infertility
Bizjournals.com
Wed, 10/5/11 - 10:50 am
Tags:
Avastin
,
Infertility
,
warnings
,
Genentech
Insurer Won’t Pay For Avastin Breast Cancer Use
Pharmalot
Mon, 10/3/11 - 11:03 am
Tags:
breast cancer
,
Avastin
,
insurance
,
Genentech
Regeneron Soars on Eye-Drug Rival Setback
TheStreet.com
Wed, 09/21/11 - 11:24 pm
Tags:
Regeneron
,
Roche
,
Avastin
,
wet-AMD
,
age-related macular degeneration
Off-Label Avastin Use, Medicare And Saving Money
Pharmalot
Wed, 09/7/11 - 09:54 am
Tags:
Medicare
,
off-label
,
Avastin
,
Roche
,
Genentech
,
age-related macular degeneration
Off-Label Avastin Injections Linked To Blindness
Pharmalot
Wed, 08/31/11 - 09:31 am
Tags:
off-label
,
blindness
,
Avastin
,
Genentech
,
Roche
Genentech pitches Avastin compromise to FDA
Fierce Pharma
Mon, 08/8/11 - 12:39 pm
Tags:
FDA
,
breast cancer
,
Avastin
,
Genentech
PDL climbs 8% on patent case ruling
Marketwatch
Mon, 07/11/11 - 12:33 pm
Tags:
PDL Biopharma
,
patents
,
Roche
,
Genentech
,
Avastin
,
Herceptin
,
Lucentis
,
Xolair
Medicare Will Continue to Cover 2 Expensive Cancer Drugs
NY Times, NY
Fri, 07/1/11 - 09:55 am
Tags:
Medicare
,
Provenge
,
prostate cancer
,
Dendreon
,
Roche
,
Avastin
,
breast cancer
What the Avastin Vote Means
Minyanville
Thu, 06/30/11 - 04:14 pm
Tags:
Avastin
,
breast cancer
,
Roche
,
FDA
,
advisory panels
Federal panel says government should revoke cancer drug Avastin's approval for breast cancer
Yahoo/AP
Wed, 06/29/11 - 07:46 pm
Tags:
Avastin
,
advisory panels
,
breast cancer
,
FDA
,
Roche
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.